THREE women with incurable breast cancer say their lives would be otherwise longer had the NHS approved a breast cancer drug. The drug was deemed too expensive by the National Institute for Health and Care Excellence (Nice) to treat HER2-low secondary breast cancer in England - around 1,000 women per year, according to Breast Cancer Now.
THREE women with incurable breast cancer say their lives would be otherwise longer had the NHS approved a breast cancer drug. Kathryn Hulland, 45, from Devon, could have more time with her daughter, Grace, six, if Enhertu had been approved by Nice . Alison Jones, aged 60 from Worthing, says: “This disease can attack anyone. You, your Mum, your daughter, your friend, and you or they might need this drug one day.
” The drug was deemed too expensive by the National Institute for Health and Care Excellence (Nice) to treat HER2-low secondary breast cancer in England - around 1,000 women per year, according to Breast Cancer Now
Women Incurable Breast Cancer NHS Drug Approval Nice Life-Extending HER2-Low Secondary Breast Cancer England Breast Cancer Now
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Breast Cancer Now funds researchers to investigate targeted radiotherapy for metastatic breast cancer in the brainResearchers are trialing a new type of targeted radiotherapy to treat secondary breast cancer tumors in the brain, thanks to new funding from Breast Cancer Now.
Read more »
'Exhausted' immune cells in healthy women could be target for breast cancer preventionResearchers at the University of Cambridge have created the world's largest catalogue of human breast cells, which has revealed early cell changes in healthy carriers of BRCA1 and BRCA2 gene mutations.
Read more »
Subtyping of breast cancer cell lines reveals insights into cancer-relevant genesCell lines are an important in vitro model in breast cancer research. A team around biochemist Dr. Sonja Eberth and bioinformatician Dr.
Read more »
Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancerA team of researchers from Hiroshima University has discovered a molecule that promotes the production of cancer cells. This molecule may prove to be a potential therapeutic target in the treatment of triple-negative breast cancer, an aggressive form of breast cancer.
Read more »
Incurable but not hopeless: How hope shapes patients' awareness of their advanced cancer prognosisHope is defined as the expectation of achieving a future good. Patients with cancer, whether it is curable or not, prioritize cure as their highest hope.
Read more »
More breast cancers detected in first evaluation of breast screening AIAn artificial intelligence (AI) breast screening solution called Mia helped doctors find an additional 12% more cancers than in routine practice, as announced today in collaboration with Kheiron Medical Technologies, NHS Grampian, the University of Aberdeen and Microsoft.
Read more »